{"id":"https://openalex.org/W7223701650","doi":"https://doi.org/10.1158/1078-0432.ccr-25-4851","title":"ENTR\u00c9E Lung: An Open-label Platform Study Investigating the Safety and Pharmacokinetics of Belrestotug Combinations in Advanced Non-Small Cell Lung Cancer","display_name":"ENTR\u00c9E Lung: An Open-label Platform Study Investigating the Safety and Pharmacokinetics of Belrestotug Combinations in Advanced Non-Small Cell Lung Cancer","publication_year":2026,"publication_date":"2026-10-26","ids":{"openalex":"https://openalex.org/W7223701650","doi":"https://doi.org/10.1158/1078-0432.ccr-25-4851","pmid":"https://pubmed.ncbi.nlm.nih.gov/42931848"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-25-4851","doi":"https://doi.org/10.1158/1078-0432.ccr-25-4851","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-25-4851","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/doi/10.1158/1078-0432.CCR-25-4851/3843215/ccr-25-4851.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://aacrjournals.org/clincancerres/article-pdf/doi/10.1158/1078-0432.CCR-25-4851/3843215/ccr-25-4851.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018054038","display_name":"David Robert Spigel","orcid":"https://orcid.org/0000-0003-3215-9465","observed_orcids":["https://orcid.org/0000-0003-3215-9465"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"David R. Spigel","raw_affiliation_strings":["Sarah Cannon Research Institute 1 Nashville, TN"],"raw_orcid":"https://orcid.org/0000-0003-3215-9465","affiliations":[{"raw_affiliation_string":"Sarah Cannon Research Institute 1 Nashville, TN","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085306324","display_name":"Giuseppe Lo Russo","orcid":"https://orcid.org/0000-0003-3224-2728","observed_orcids":["https://orcid.org/0000-0003-3224-2728"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giuseppe Lo Russo","raw_affiliation_strings":["Fondazione IRCCS Istituto Nazionale dei Tumori 2 Milan"],"raw_orcid":"https://orcid.org/0000-0003-3224-2728","affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori 2 Milan","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102750304","display_name":"Sophie Cousin","orcid":"https://orcid.org/0000-0002-4847-6329","observed_orcids":["https://orcid.org/0000-0002-4847-6329"]},"institutions":[{"id":"https://openalex.org/I4210134409","display_name":"Institut Bergoni\u00e9","ror":"https://ror.org/02yw1f353","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210134409"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sophie Cousin","raw_affiliation_strings":["Institut Bergoni\u00e9 3 Bordeaux"],"raw_orcid":"https://orcid.org/0000-0002-4847-6329","affiliations":[{"raw_affiliation_string":"Institut Bergoni\u00e9 3 Bordeaux","institution_ids":["https://openalex.org/I4210134409"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050766137","display_name":"Pilar Garrido","orcid":"https://orcid.org/0000-0002-5899-6125","observed_orcids":["https://orcid.org/0000-0002-5899-6125"]},"institutions":[{"id":"https://openalex.org/I4210127475","display_name":"Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria","ror":"https://ror.org/03fftr154","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210127475"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Pilar Garrido","raw_affiliation_strings":["Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria 4 Madrid"],"raw_orcid":"https://orcid.org/0000-0002-5899-6125","affiliations":[{"raw_affiliation_string":"Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria 4 Madrid","institution_ids":["https://openalex.org/I4210127475"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082061757","display_name":"Quincy Siu-Chung Chu","orcid":"https://orcid.org/0000-0003-4814-3126","observed_orcids":["https://orcid.org/0000-0003-4814-3126"]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Quincy Chu","raw_affiliation_strings":["University of Alberta 5 Edmonton, AB"],"raw_orcid":"https://orcid.org/0000-0003-4814-3126","affiliations":[{"raw_affiliation_string":"University of Alberta 5 Edmonton, AB","institution_ids":["https://openalex.org/I154425047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047971484","display_name":"Laura Medina","orcid":"https://orcid.org/0000-0002-8041-3547","observed_orcids":["https://orcid.org/0000-0002-8041-3547"]},"institutions":[{"id":"https://openalex.org/I4210157481","display_name":"Hospital Cl\u00ednico Universitario Virgen de la Victoria","ror":"https://ror.org/05xxs2z38","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I158283456","https://openalex.org/I4210157481"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Laura Medina Rodriguez","raw_affiliation_strings":["Hospital Cl\u00ednico Universitario Virgen de la Victoria 6 MALAGA"],"raw_orcid":"https://orcid.org/0000-0002-8041-3547","affiliations":[{"raw_affiliation_string":"Hospital Cl\u00ednico Universitario Virgen de la Victoria 6 MALAGA","institution_ids":["https://openalex.org/I4210157481"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046219779","display_name":"Adrian G. Sacher","orcid":"https://orcid.org/0000-0001-7865-2701","observed_orcids":["https://orcid.org/0000-0001-7865-2701"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Adrian Sacher","raw_affiliation_strings":["Princess Margaret Cancer Centre 7 Toronto, ON"],"raw_orcid":"https://orcid.org/0000-0001-7865-2701","affiliations":[{"raw_affiliation_string":"Princess Margaret Cancer Centre 7 Toronto, ON","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057761387","display_name":"Parneet Kaur Cheema","orcid":"https://orcid.org/0000-0002-9680-7073","observed_orcids":["https://orcid.org/0000-0002-9680-7073","https://orcid.org/0000-0002-2666-3481"]},"institutions":[{"id":"https://openalex.org/I4210129503","display_name":"William Osler Health System","ror":"https://ror.org/03d1xjg58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4210129503"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Parneet Cheema","raw_affiliation_strings":["William Osler Health System 8 Toronto, Ontario"],"raw_orcid":"https://orcid.org/0000-0002-9680-7073","affiliations":[{"raw_affiliation_string":"William Osler Health System 8 Toronto, Ontario","institution_ids":["https://openalex.org/I4210129503"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030643739","display_name":"Manolo D\u2019Arcangelo","orcid":"https://orcid.org/0000-0003-0409-7762","observed_orcids":["https://orcid.org/0000-0003-0409-7762"]},"institutions":[{"id":"https://openalex.org/I4210107542","display_name":"Azienda Unit\u00e0 Sanitaria Locale Della Romagna","ror":"https://ror.org/01rqq3d62","country_code":"IT","type":"government","lineage":["https://openalex.org/I4210107542"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Manolo D\u2019Arcangelo","raw_affiliation_strings":["Azienda Unit\u00e0 Sanitaria Locale Della Romagna 9 Ravenna"],"raw_orcid":"https://orcid.org/0000-0003-0409-7762","affiliations":[{"raw_affiliation_string":"Azienda Unit\u00e0 Sanitaria Locale Della Romagna 9 Ravenna","institution_ids":["https://openalex.org/I4210107542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103414251","display_name":"Giulia Rossi","orcid":"https://orcid.org/0009-0006-5640-5527","observed_orcids":["https://orcid.org/0009-0006-5640-5527"]},"institutions":[{"id":"https://openalex.org/I102064193","display_name":"University of Siena","ror":"https://ror.org/01tevnk56","country_code":"IT","type":"education","lineage":["https://openalex.org/I102064193"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giulia Rossi","raw_affiliation_strings":["University of Siena 10"],"raw_orcid":"https://orcid.org/0009-0006-5640-5527","affiliations":[{"raw_affiliation_string":"University of Siena 10","institution_ids":["https://openalex.org/I102064193"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102811783","display_name":"Antara Majumdar","orcid":"https://orcid.org/0000-0002-3818-3696","observed_orcids":["https://orcid.org/0000-0002-3818-3696"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Antara Majumdar","raw_affiliation_strings":["GlaxoSmithKline (United States) 11 Collegeville, PA"],"raw_orcid":"https://orcid.org/0000-0002-3818-3696","affiliations":[{"raw_affiliation_string":"GlaxoSmithKline (United States) 11 Collegeville, PA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052952768","display_name":"Patrick Hanafin","orcid":"https://orcid.org/0009-0003-7129-0404","observed_orcids":["https://orcid.org/0009-0003-7129-0404"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick Hanafin","raw_affiliation_strings":["GlaxoSmithKline (United States) 12 Collegeville, Pensylvannia"],"raw_orcid":"https://orcid.org/0009-0003-7129-0404","affiliations":[{"raw_affiliation_string":"GlaxoSmithKline (United States) 12 Collegeville, Pensylvannia","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078571350","display_name":"Mirella Georgouli","orcid":"https://orcid.org/0009-0001-6774-0017","observed_orcids":["https://orcid.org/0009-0001-6774-0017"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mirella Georgouli","raw_affiliation_strings":["GlaxoSmithKline (United Kingdom) 13 Stevenage"],"raw_orcid":"https://orcid.org/0009-0001-6774-0017","affiliations":[{"raw_affiliation_string":"GlaxoSmithKline (United Kingdom) 13 Stevenage","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000994874","display_name":"Reza Mozaffari","orcid":"https://orcid.org/0000-0002-0738-7880","observed_orcids":["https://orcid.org/0000-0002-0738-7880"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Reza Mozaffari","raw_affiliation_strings":["GlaxoSmithKline (United States) 14 Collegeville, Pennsylvania"],"raw_orcid":"https://orcid.org/0000-0002-0738-7880","affiliations":[{"raw_affiliation_string":"GlaxoSmithKline (United States) 14 Collegeville, Pennsylvania","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045488763","display_name":"Magdalena Kijewska","orcid":"https://orcid.org/0009-0000-2917-1530","observed_orcids":["https://orcid.org/0009-0000-2917-1530"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Magdalena Kijewska","raw_affiliation_strings":["GlaxoSmithKline (United Kingdom) 13 Stevenage"],"raw_orcid":"https://orcid.org/0009-0000-2917-1530","affiliations":[{"raw_affiliation_string":"GlaxoSmithKline (United Kingdom) 13 Stevenage","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028479976","display_name":"Davinder S. Theti","orcid":"https://orcid.org/0009-0002-6919-0319","observed_orcids":["https://orcid.org/0009-0002-6919-0319"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Davinder Theti","raw_affiliation_strings":["GlaxoSmithKline (United Kingdom) 15 London"],"raw_orcid":"https://orcid.org/0009-0002-6919-0319","affiliations":[{"raw_affiliation_string":"GlaxoSmithKline (United Kingdom) 15 London","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018418873","display_name":"Dawn Baxter","orcid":"https://orcid.org/0009-0003-4207-4657","observed_orcids":["https://orcid.org/0009-0003-4207-4657"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dawn Baxter","raw_affiliation_strings":["GlaxoSmithKline (United States) 11 Collegeville, PA"],"raw_orcid":"https://orcid.org/0009-0003-4207-4657","affiliations":[{"raw_affiliation_string":"GlaxoSmithKline (United States) 11 Collegeville, PA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067872357","display_name":"Fabrizio Trinchese","orcid":"https://orcid.org/0000-0002-7667-0778","observed_orcids":["https://orcid.org/0000-0002-7667-0778"]},"institutions":[{"id":"https://openalex.org/I4210141913","display_name":"GlaxoSmithKline (Switzerland)","ror":"https://ror.org/03sqbp894","country_code":"CH","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210141913"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Fabrizio Trinchese","raw_affiliation_strings":["GlaxoSmithKline (Switzerland) 16 Baar"],"raw_orcid":"https://orcid.org/0000-0002-7667-0778","affiliations":[{"raw_affiliation_string":"GlaxoSmithKline (Switzerland) 16 Baar","institution_ids":["https://openalex.org/I4210141913"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148428577","display_name":"Ivan Diaz Padilla","orcid":"https://orcid.org/0009-0001-6800-2462","observed_orcids":["https://orcid.org/0009-0001-6800-2462"]},"institutions":[{"id":"https://openalex.org/I4210141913","display_name":"GlaxoSmithKline (Switzerland)","ror":"https://ror.org/03sqbp894","country_code":"CH","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210141913"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Ivan Diaz-Padilla","raw_affiliation_strings":["GlaxoSmithKline (Switzerland) 17"],"raw_orcid":"https://orcid.org/0009-0001-6800-2462","affiliations":[{"raw_affiliation_string":"GlaxoSmithKline (Switzerland) 17","institution_ids":["https://openalex.org/I4210141913"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046728958","display_name":"Martin Reck","orcid":"https://orcid.org/0000-0002-5348-4462","observed_orcids":["https://orcid.org/0000-0002-5348-4462"]},"institutions":[{"id":"https://openalex.org/I4210140903","display_name":"LungenClinic Grosshansdorf","ror":"https://ror.org/041wfjw90","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210140903"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Martin Reck","raw_affiliation_strings":["LungenClinic Grosshansdorf 18 Grosshansdorf"],"raw_orcid":"https://orcid.org/0000-0002-5348-4462","affiliations":[{"raw_affiliation_string":"LungenClinic Grosshansdorf 18 Grosshansdorf","institution_ids":["https://openalex.org/I4210140903"]}]}],"institutions":[],"countries_distinct_count":8,"institutions_distinct_count":13,"corresponding_author_ids":["https://openalex.org/A5018054038"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.80776638,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.009600000455975533,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dostarlimab","display_name":"dostarlimab","score":0.9900000095367432},{"id":"https://openalex.org/keywords/anti-pd-1-antibody","display_name":"anti-PD-1","score":0.6850000023841858},{"id":"https://openalex.org/keywords/advanced-non-small-cell-lung-cancer","display_name":"advanced non-small cell lung cancer","score":0.8169999718666077},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.7210000157356262},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.6890000104904175},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9100000262260437},{"id":"https://openalex.org/keywords/treatment-related-adverse-events","display_name":"treatment-related adverse events","score":0.7620000243186951},{"id":"https://openalex.org/keywords/pd-1-pd-l1-blockade","display_name":"PD-1/PD-L1 blockade","score":0.5929999947547913},{"id":"https://openalex.org/keywords/tigit","display_name":"TIGIT","score":0.44200000166893005},{"id":"https://openalex.org/keywords/cd96","display_name":"CD96","score":0.9480000138282776}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8985999822616577},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.7552000284194946},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.7480000257492065},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7129999995231628},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5960000157356262},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5909000039100647},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5795999765396118},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5267999768257141},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.44449999928474426},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.43790000677108765},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.41690000891685486},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.38679999113082886},{"id":"https://openalex.org/C2776178081","wikidata":"https://www.wikidata.org/wiki/Q3286546","display_name":"Respiratory disease","level":3,"score":0.3781000077724457},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.37720000743865967},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3716999888420105},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.36800000071525574},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.35749998688697815},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3483999967575073},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3409000039100647},{"id":"https://openalex.org/C2777334693","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Maximum tolerated dose","level":3,"score":0.3280999958515167},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.32420000433921814},{"id":"https://openalex.org/C204243189","wikidata":"https://www.wikidata.org/wiki/Q1363085","display_name":"Randomization","level":3,"score":0.3147999942302704},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.2881999909877777},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.28139999508857727},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.27250000834465027},{"id":"https://openalex.org/C3018359032","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Safety profile","level":3,"score":0.2720000147819519},{"id":"https://openalex.org/C2983914783","wikidata":"https://www.wikidata.org/wiki/Q3286546","display_name":"Lung disease","level":3,"score":0.26660001277923584},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.25920000672340393},{"id":"https://openalex.org/C2778807442","wikidata":"https://www.wikidata.org/wiki/Q6152005","display_name":"Treatment of lung cancer","level":3,"score":0.25369998812675476},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.25189998745918274}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.ccr-25-4851","doi":"https://doi.org/10.1158/1078-0432.ccr-25-4851","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-25-4851","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/doi/10.1158/1078-0432.CCR-25-4851/3843215/ccr-25-4851.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:42931848","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42931848","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.ccr-25-4851","doi":"https://doi.org/10.1158/1078-0432.ccr-25-4851","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-25-4851","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/doi/10.1158/1078-0432.CCR-25-4851/3843215/ccr-25-4851.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"},{"id":"https://openalex.org/F4320316629","display_name":"Agios Pharmaceuticals","ror":"https://ror.org/002x06r10"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7223701650.pdf","grobid_xml":"https://content.openalex.org/works/W7223701650.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4408555264","https://openalex.org/W4402565599","https://openalex.org/W4281395825","https://openalex.org/W7204454387","https://openalex.org/W3088470272","https://openalex.org/W2260067559","https://openalex.org/W3088018189","https://openalex.org/W4388071789","https://openalex.org/W4388045839","https://openalex.org/W3212804507"],"abstract_inverted_index":{"Purpose":[0],"ENTR\u00c9E":[1],"Lung":[2],"(NCT03739710)":[3],"was":[4,100,180,191,216],"a":[5],"global,":[6],"open-label,":[7],"platform":[8],"study":[9,46,89],"investigating":[10],"novel":[11],"immunotherapy":[12,242],"combinations":[13],"in":[14,114,147,156,202,225],"advanced":[15,228],"non-small":[16],"cell":[17],"lung":[18],"cancer":[19],"(NSCLC)":[20],"following":[21],"progression":[22],"on":[23],"anti-PD-(L)1":[24],"and":[25,43,53,80,122,152,159,198,205],"platinum-based":[26],"treatment.":[27],"We":[28],"report":[29],"findings":[30],"with":[31,37,50,212],"dostarlimab":[32,60,73],"(anti-PD-1)":[33],"plus":[34,63,76,210],"belrestotug":[35,64,77],"(anti-TIGIT)":[36],"or":[38,111,213],"without":[39,214],"nelistotug":[40,81,109],"(anti-CD96).":[41],"Patients":[42],"Methods":[44],"The":[45],"included":[47],"safety":[48,57,121],"cohorts":[49],"dose":[51,68,85],"escalation":[52],"expansion:":[54],"Arm":[55,103],"4":[56,148,194],"cohort":[58,99],"(Arm4-safety),":[59],"500":[61,74],"mg":[62,66,75,79,83,113],"200-1000":[65],"(initial":[67,84],"level:":[69,86],"400":[70,78],"mg);":[71,88,186],"Arm5-safety,":[72],"210-1400":[82],"700":[87],"treatments":[90],"were":[91,120,127,163],"administered":[92],"intravenously":[93],"every":[94],"3":[95,153],"weeks.":[96],"A":[97],"randomized":[98],"added":[101],"to":[102,108,168,234],"5":[104,196],"(Arm5-randomized),":[105],"assigning":[106],"patients":[107,126,155,172,201,236],"210":[110,185],"1400":[112,139],"the":[115],"triplet":[116],"combination.":[117],"Primary":[118],"endpoints":[119],"tolerability.":[123],"Results":[124],"Sixty-two":[125],"enrolled":[128],"(n=24":[129],"Arm4-safety;":[130],"n=17":[131],"Arm5-safety;":[132],"n=21":[133],"Arm5-randomized":[134],"[n=11,":[135],"200":[136],"mg;":[137],"n=10,":[138],"mg]).":[140],"Grade":[141],"\u22653":[142],"treatment-related":[143],"adverse":[144,169],"events":[145],"occurred":[146],"(17%),":[149,195],"1":[150],"(6%)":[151],"(14%)":[154],"Arm4-safety,":[157,203],"Arm5-safety":[158,204],"Arm5-randomized,":[160,206],"respectively.":[161,207],"There":[162,179],"few":[164],"treatment":[165],"discontinuations":[166],"due":[167],"events.":[170],"Most":[171],"exhibited":[173],"progressive":[174],"disease":[175,188],"as":[176],"best":[177],"response.":[178],"one":[181],"partial":[182],"response":[183],"(Arm5-randomized,":[184],"stable":[187],"\u226512":[189],"weeks":[190],"experienced":[192],"by":[193],"(29%)":[197],"2":[199],"(10%)":[200],"Conclusions":[208],"Dostarlimab":[209],"belrestotug,":[211],"nelistotug,":[215],"well":[217],"tolerated":[218],"but":[219],"demonstrated":[220],"no":[221],"clinically":[222],"meaningful":[223],"activity":[224],"previously":[226],"treated":[227],"NSCLC.":[229],"Further":[230],"research":[231],"is":[232],"required":[233],"identify":[235],"who":[237],"may":[238],"benefit":[239],"from":[240],"other":[241],"combinations.":[243]},"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2026-10-27T00:00:00"}